# FDA Warning Letter: EzriCare LLC
> 2024-02-27 · Division of Pharmaceutical Quality Operations I · `8b774081ad000a03`
## Letter
- **Company:** EzriCare LLC
- **Posted Date:** 2024-02-27
- **Letter Issue Date:** 2024-02-13
- **Issuing Office:** Division of Pharmaceutical Quality Operations I
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*